Skip to main content

Table 2 Comparison of clinicopathologic and radiological features between patients with and without LVI

From: Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer

Parameters

No. of patients without LVI (n = 197)

No. of patients with LVI (n = 104)

P value*

Age (years)

 Mean

50.0 ± 10.8

49.6 ± 11.4

0.767

 Median

49.0

48.0

  < 50 (n = 167)

105 (62.9)

62 (37.1)

0.294

  ≥ 50 (n = 134)

92 (68.7)

42 (31.3)

Tumor location

 Upper-outer quadrant (n = 14 6)

96 (65.8)

50 (34.2)

0.028

 Lower-outer quadrant (n = 44 )

33 (75.0)

11 (25.0)

 Upper-inner quadrant (n = 74 )

51 (68.9)

23 (31.1)

 Lower-inner quadrant (n = 19 ) quadrant (n = 31)

11 (57.9)

8 (42.1)

 Central position (n = 18)

6 (33.3)

12 (66.7)

Tumor size (mm)

  < 30 (n = 176)

124 (70.5)

52 (29.5)

0.030

  ≥ 30 (n = 125)

73 (58.4)

52 (41.6)

Margins

 Well-defined (n = 95)

82 (86.3)

13 (13.7)

< 0.001

 Ill-defined (n = 206)

115 (55.8)

91 (44.2)

Lobulation sign Hyperechogenicity (n = 61)

 Absence (n = 135)

110 (81.5)

25 (18.5)

<  0.001

 Presence (n = 166)

87 (52.4)

79 (47.6)

Spiculation sign

 Absence (n = 122)

88 (72.1)

34 (27.9)

0.044

 Presence (n = 179)

109 (60.9)

70 (39.1)

MRI-reported ALNM

 Absent (n = 92)

43 (46.7)

49 (53.3)

< 0.001

 Single (n = 51)

32 (62.7)

19 (37.3)

 Multiple (n = 158)

122 (77.2)

36 (22.8)

DWI appearance

 Slight-moderate hyperintensity (n = 113)

92 (81.4)

21 (18.6)

< 0.001

 Marked hyperintensity (n = 188)

105 (55.9)

83 (44.1)

TIC pattern

 Type I (n = 25)

24 (96.0)

1 (4.0)

< 0.001

 Type II (n = 229)

152 (66.4)

77 (33.6)

 Type III (n = 47)

21 (44.7)

26 (55.3)

ER (%)

  < 50 (n = 116)

72 (62.1)

44 (37.9)

0.329

  ≥ 50 (n = 185)

125 (67.6)

60 (32.4)

PR (%)

  < 50 (n = 191)

120 (62.8)

71 (37.2)

0.208

  ≥ 50 (n = 110)

77 (70.0)

33 (30.0)

HER2

 - (n = 23)

19 (82.6)

4 (17.4)

0.132

  + (n = 63)

45 (71.4)

18 (28.6)

 ++ (n = 149)

93 (63.3)

54 (36.7)

 +++ (n = 68)

40 (58.8)

28 (41.2)

Ki-67 (%) index

  < 20 (n = 99)

64 (64.6)

35 (35.4)

0.838

  ≥ 20 (n = 202)

133 (65.8)

69 (34.2)

Histological type

 IDC grade 3 (n = 106)

58 (54.7)

48 (45.3)

< 0.001

 IDC grade 2 (n = 149)

98 (65.8)

51 (34.2)

 DCIS (n = 46)

41 (89.0)

5 (11.0)

  1. Note: unless otherwise indicated, data are numbers of nodules, and numbers in parentheses are percentages. *P value were calculated by using generalized estimating equation analysis. DWI diffusion-weighted imaging, TIC time-intensity curve, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor, IDC invasive ductal carcinoma. DCIS ductal carcinoma in situ